chevron_leftBack
As of 15 June 2026, Acrobiosystems Co.,Ltd. has a market cap of $1.12B USD, ranking #10059 globally and #2777 in China.
It ranks #885 in the Healthcare sector, and #334 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$1.12BUSD
7.6B CNY
Enterprise Value
$941.67MUSD
6.37B CNY
Revenue (TTM)
$123.69MUSD
838.12M CNY
EBITDA (TTM)
$35.95MUSD
243.3M CNY
Net Income (TTM)
$24.43MUSD
165.57M CNY
EBITDA Margin
29%
Profit Margin
20%
PE Ratio
44.9
Forward PE
29.1
PS Ratio
9.1
PB Ratio
2.9
EV/EBITDA
32.3
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Yiding Chen
open_in_new
Employees
869
Founded
2010
Website
acrobiosystems.cn
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -1.7% | -3.2% | 5.6% | -22% | -31% | 33% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
301080
北京百普赛斯生物科技股份有限公司 Class A
ISIN: CNE100004S13
Shares Out.:
Shares Outstanding:
167.178M1
Shares Float:
105.889M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
44.70 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Acrobiosystems Co.,Ltd.
Acrobiosystems Co.,Ltd. engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and scientific research institutions. The company has a collaboration with Diagnostic Biochips Inc for neurological drug discovery and commercialization. The company was founded in 2010 and is based in Beijing, China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SSE: 600276
|
$53.85B
5K%
364.89B CNY
|
44.9
|
|
SSE: 603259
|
$49.64B
4K%
336.36B CNY
|
17.2
|
|
SHEK: 3692
|
$28.52B
2K%
223.48B HKD
|
35.7
|
|
SHEK: 1801
|
$18.8B
2K%
147.32B HKD
|
162.3
|
|
SSE: 688506
|
$16.51B
1K%
111.89B CNY
|
-
|
|
SHEK: 9926
|
$16.01B
1K%
125.46B HKD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
68K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
49K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
32K%
|
97.4
|
|
SIX: RO
|
$321.52B
29K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.84B
26K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.65B
24K%
218.9B CHF
|
20.5
|
chevron_leftBack